source
- Podcast explores the limits of "blue zones" concept in aging researchOn a recent First Opinion podcast, medical journalist Shelley Wood and cardiologist Eric Topol discussed the "blue zones" concept and its relevance to aging research. They traced the idea back to…
- Bristol Myers Squibb signs up to $15.2 billion partnership with China's Hengrui PharmaBristol Myers Squibb announced a licensing partnership with China's Hengrui Pharma covering more than a dozen early-stage drug programs. The agreement includes a $600 million upfront payment to He…